Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth

Guangxu He, Yu Shi, Joohyun Lim, Teresita Bellido, Jiangdong Ni, Fanxin Long

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Bone morphogenetic proteins (Bmp) are well-known to induce bone formation following chondrogenesis, but the direct role of Bmp signaling in the osteoblast lineage is not completely understood. We have recently shown that deletion of the receptor Bmpr1a in the osteoblast lineage with Dmp1-Cre reduces osteoblast activity in general but stimulates proliferation of preosteoblasts specifically in the cancellous bone region, resulting in diminished periosteal bone growth juxtaposed with excessive cancellous bone formation. Because expression of sclerostin (SOST), a secreted Wnt antagonist, is notably reduced in the Bmpr1a-deficient osteocytes, we have genetically tested the hypothesis that increased Wnt signaling might mediate the increase in cancellous bone formation in response to Bmpr1a deletion. Forced expression of human SOST from a Dmp1 promoter fragment partially rescues preosteoblast hyperproliferation and cancellous bone overgrowth in the Bmpr1a mutant mice, demonstrating functional interaction between Bmp and Wnt signaling in the cancellous bone compartment. To test whether increased Wnt signaling can compensate for the defect in periosteal growth caused by Bmpr1a deletion, we have generated compound mutants harboring a hyperactive mutation (A214V) in the Wnt receptor Lrp5. However, the mutant Lrp5 does not restore periosteal bone growth in the Bmpr1a-deficient mice. Thus, Bmp signaling restricts cancellous bone accrual partly through induction of SOST that limits preosteoblast proliferation, but promotes periosteal bone growth apparently independently of Wnt activation.

Original languageEnglish (US)
Article number17016
JournalBone Research
Volume5
DOIs
StatePublished - Jun 6 2017

Fingerprint

Bone Morphogenetic Proteins
Bone Development
Osteoblasts
Osteogenesis
Wnt Receptors
Chondrogenesis
Osteocytes
Cancellous Bone
Mutation
Growth

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Histology
  • Physiology

Cite this

Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth. / He, Guangxu; Shi, Yu; Lim, Joohyun; Bellido, Teresita; Ni, Jiangdong; Long, Fanxin.

In: Bone Research, Vol. 5, 17016, 06.06.2017.

Research output: Contribution to journalArticle

He, Guangxu ; Shi, Yu ; Lim, Joohyun ; Bellido, Teresita ; Ni, Jiangdong ; Long, Fanxin. / Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth. In: Bone Research. 2017 ; Vol. 5.
@article{322fab55b74543f7aaa342ffbdfb9714,
title = "Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth",
abstract = "Bone morphogenetic proteins (Bmp) are well-known to induce bone formation following chondrogenesis, but the direct role of Bmp signaling in the osteoblast lineage is not completely understood. We have recently shown that deletion of the receptor Bmpr1a in the osteoblast lineage with Dmp1-Cre reduces osteoblast activity in general but stimulates proliferation of preosteoblasts specifically in the cancellous bone region, resulting in diminished periosteal bone growth juxtaposed with excessive cancellous bone formation. Because expression of sclerostin (SOST), a secreted Wnt antagonist, is notably reduced in the Bmpr1a-deficient osteocytes, we have genetically tested the hypothesis that increased Wnt signaling might mediate the increase in cancellous bone formation in response to Bmpr1a deletion. Forced expression of human SOST from a Dmp1 promoter fragment partially rescues preosteoblast hyperproliferation and cancellous bone overgrowth in the Bmpr1a mutant mice, demonstrating functional interaction between Bmp and Wnt signaling in the cancellous bone compartment. To test whether increased Wnt signaling can compensate for the defect in periosteal growth caused by Bmpr1a deletion, we have generated compound mutants harboring a hyperactive mutation (A214V) in the Wnt receptor Lrp5. However, the mutant Lrp5 does not restore periosteal bone growth in the Bmpr1a-deficient mice. Thus, Bmp signaling restricts cancellous bone accrual partly through induction of SOST that limits preosteoblast proliferation, but promotes periosteal bone growth apparently independently of Wnt activation.",
author = "Guangxu He and Yu Shi and Joohyun Lim and Teresita Bellido and Jiangdong Ni and Fanxin Long",
year = "2017",
month = "6",
day = "6",
doi = "10.1038/boneres.2017.16",
language = "English (US)",
volume = "5",
journal = "Bone Research",
issn = "2095-4700",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth

AU - He, Guangxu

AU - Shi, Yu

AU - Lim, Joohyun

AU - Bellido, Teresita

AU - Ni, Jiangdong

AU - Long, Fanxin

PY - 2017/6/6

Y1 - 2017/6/6

N2 - Bone morphogenetic proteins (Bmp) are well-known to induce bone formation following chondrogenesis, but the direct role of Bmp signaling in the osteoblast lineage is not completely understood. We have recently shown that deletion of the receptor Bmpr1a in the osteoblast lineage with Dmp1-Cre reduces osteoblast activity in general but stimulates proliferation of preosteoblasts specifically in the cancellous bone region, resulting in diminished periosteal bone growth juxtaposed with excessive cancellous bone formation. Because expression of sclerostin (SOST), a secreted Wnt antagonist, is notably reduced in the Bmpr1a-deficient osteocytes, we have genetically tested the hypothesis that increased Wnt signaling might mediate the increase in cancellous bone formation in response to Bmpr1a deletion. Forced expression of human SOST from a Dmp1 promoter fragment partially rescues preosteoblast hyperproliferation and cancellous bone overgrowth in the Bmpr1a mutant mice, demonstrating functional interaction between Bmp and Wnt signaling in the cancellous bone compartment. To test whether increased Wnt signaling can compensate for the defect in periosteal growth caused by Bmpr1a deletion, we have generated compound mutants harboring a hyperactive mutation (A214V) in the Wnt receptor Lrp5. However, the mutant Lrp5 does not restore periosteal bone growth in the Bmpr1a-deficient mice. Thus, Bmp signaling restricts cancellous bone accrual partly through induction of SOST that limits preosteoblast proliferation, but promotes periosteal bone growth apparently independently of Wnt activation.

AB - Bone morphogenetic proteins (Bmp) are well-known to induce bone formation following chondrogenesis, but the direct role of Bmp signaling in the osteoblast lineage is not completely understood. We have recently shown that deletion of the receptor Bmpr1a in the osteoblast lineage with Dmp1-Cre reduces osteoblast activity in general but stimulates proliferation of preosteoblasts specifically in the cancellous bone region, resulting in diminished periosteal bone growth juxtaposed with excessive cancellous bone formation. Because expression of sclerostin (SOST), a secreted Wnt antagonist, is notably reduced in the Bmpr1a-deficient osteocytes, we have genetically tested the hypothesis that increased Wnt signaling might mediate the increase in cancellous bone formation in response to Bmpr1a deletion. Forced expression of human SOST from a Dmp1 promoter fragment partially rescues preosteoblast hyperproliferation and cancellous bone overgrowth in the Bmpr1a mutant mice, demonstrating functional interaction between Bmp and Wnt signaling in the cancellous bone compartment. To test whether increased Wnt signaling can compensate for the defect in periosteal growth caused by Bmpr1a deletion, we have generated compound mutants harboring a hyperactive mutation (A214V) in the Wnt receptor Lrp5. However, the mutant Lrp5 does not restore periosteal bone growth in the Bmpr1a-deficient mice. Thus, Bmp signaling restricts cancellous bone accrual partly through induction of SOST that limits preosteoblast proliferation, but promotes periosteal bone growth apparently independently of Wnt activation.

UR - http://www.scopus.com/inward/record.url?scp=85020408777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020408777&partnerID=8YFLogxK

U2 - 10.1038/boneres.2017.16

DO - 10.1038/boneres.2017.16

M3 - Article

AN - SCOPUS:85020408777

VL - 5

JO - Bone Research

JF - Bone Research

SN - 2095-4700

M1 - 17016

ER -